|
BIRC6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.19819999999205E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.50989999999829E-05 |
| Normal-vs-Stage2 |
7.623700E-02 |
| Normal-vs-Stage3 |
2.022200E-02 |
| Normal-vs-Stage4 |
2.607600E-02 |
| Stage1-vs-Stage2 |
4.854800E-01 |
| Stage1-vs-Stage3 |
6.853600E-01 |
| Stage1-vs-Stage4 |
6.081600E-01 |
| Stage2-vs-Stage3 |
7.656800E-01 |
| Stage2-vs-Stage4 |
3.440400E-01 |
| Stage3-vs-Stage4 |
4.677000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58404999999195E-05 |
| Normal-vs-AfricanAmerican |
2.962400E-03 |
| Normal-vs-Asian |
1.691700E-02 |
| Caucasian-vs-AfricanAmerican |
6.773000E-01 |
| Caucasian-vs-Asian |
8.929400E-01 |
| AfricanAmerican-vs-Asian |
7.944200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06080000006337E-07 |
| Normal-vs-Female |
5.490800E-01 |
| Male-vs-Female |
2.447200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.978870E-03 |
| Normal-vs-Extreme_Weight |
1.93589999586408E-08 |
| Normal-vs-Obese |
2.613900E-02 |
| Normal-vs-Extreme_Obese |
2.037400E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.679600E-01 |
| Normal_Weight-vs-Obese |
2.244200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.826800E-01 |
| Extreme_Weight-vs-Obese |
3.262500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.832400E-01 |
| Obese-vs-Extreme_Obese |
2.873200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.896800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.093960E-02 |
| Normal-vs-Age(61-80Yrs) |
1.20599999986482E-07 |
| Normal-vs-Age(81-100Yrs) |
4.12100000000137E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.126600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.672000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.917700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.101700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.191700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.095200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.66469999998797E-06 |
| Normal-VS-Type2 PRCC |
1.194980E-04 |
| Normal-VS-KIRP CIMP |
9.508600E-01 |
| Normal-VS-Unclassified PRCC |
3.619000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.890400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.638100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.244200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.390000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.392300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.890600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.67349999980316E-07 |
| Normal-vs-N1 |
5.389800E-02 |
| Normal-vs-N2 |
2.847800E-01 |
| N0-vs-N1 |
9.007700E-02 |
| N0-vs-N2 |
2.598200E-01 |
| N1-vs-N2 |
8.633000E-01 |
|
|
